| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/1999 | WO1999033815A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033811A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
| 07/08/1999 | WO1999033806A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | WO1999033804A1 Tetrahydrobenzindole derivatives |
| 07/08/1999 | WO1999033803A1 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
| 07/08/1999 | WO1999033801A1 Tripeptidyl peptidase inhibitors |
| 07/08/1999 | WO1999033800A1 Indole derivatives as inhibitors or factor xa |
| 07/08/1999 | WO1999033799A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 07/08/1999 | WO1999033797A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
| 07/08/1999 | WO1999033793A2 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033789A1 SUBSTITUTED β-ALANINES |
| 07/08/1999 | WO1999033786A1 Anti-inflammatory compounds |
| 07/08/1999 | WO1999033782A1 Anticancer platinum (iv) complexes for oral administration |
| 07/08/1999 | WO1999033781A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 07/08/1999 | WO1999033780A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof |
| 07/08/1999 | WO1999033521A2 Use of chelating agents in the treatment of atherosclerotic conditions |
| 07/08/1999 | WO1999033491A1 Sustained release medicinal compositions |
| 07/08/1999 | WO1999033490A1 Sustained release medicinal compositions |
| 07/08/1999 | WO1999033489A1 Sustained release medicinal compositions |
| 07/08/1999 | WO1999033483A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 07/08/1999 | WO1999033478A1 Sodium ion absorption inhibitors, sodium ion excretion accelerators, and preventive and therapeutic agents for diseases resulting from excessive intake of common salt |
| 07/08/1999 | WO1999033477A1 Drug-directed mutagenesis/drug-driven selection for lethal mutants |
| 07/08/1999 | WO1999033476A1 Hyperhydrated citicoline, process and use |
| 07/08/1999 | WO1999033475A1 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| 07/08/1999 | WO1999033474A1 The use of mannose for combating protein loss enteropathy |
| 07/08/1999 | WO1999033473A1 Remedies for intramedullary diseases |
| 07/08/1999 | WO1999033472A1 Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear |
| 07/08/1999 | WO1999033470A1 ANTI-$i(HELICOBACTER PYLORI) |
| 07/08/1999 | WO1999033469A1 Benzoxazine compounds for enhancing synaptic response |
| 07/08/1999 | WO1999033468A1 Method for treating hyperoxia |
| 07/08/1999 | WO1999033467A1 Method and composition of an oral preparation of itraconazole |
| 07/08/1999 | WO1999033466A1 Pharmaceutical composition for oral administration |
| 07/08/1999 | WO1999033465A1 Remedy for neurodegenerative diseases___________________________ |
| 07/08/1999 | WO1999033464A1 Water-base liquid preparation |
| 07/08/1999 | WO1999033463A1 SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b) |
| 07/08/1999 | WO1999033461A1 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities |
| 07/08/1999 | WO1999033460A1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 07/08/1999 | WO1999033459A1 Methods of inactivating bacteria including bacterial spores |
| 07/08/1999 | WO1999033458A1 Medicinal composition for percutaneous administration |
| 07/08/1999 | WO1999033456A1 Pharmaceutical compositions containing bupropion hydrochloride and an inorganic acid stabilizer |
| 07/08/1999 | WO1999033455A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system |
| 07/08/1999 | WO1999033454A2 S-procyclidine for treating urinary incontinence |
| 07/08/1999 | WO1999033453A2 R-procyclidine for treating urinary incontinence |
| 07/08/1999 | WO1999033452A2 Amine-containing copolymers as bile acid sequestrants |
| 07/08/1999 | WO1999033451A2 Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin |
| 07/08/1999 | WO1999033450A2 Pharmaceutical composition containing sibutramine and orlistat |
| 07/08/1999 | WO1999033448A1 Tablet for instant and prolonged release of one or more active substances |
| 07/08/1999 | WO1999033434A2 Use of inorganic-organic hybrid prepolymers |
| 07/08/1999 | WO1999033431A2 Preparation and selection of pharmaceutically useful compounds from a diverse universal library |
| 07/08/1999 | WO1999033355A2 Fat blend |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | WO1999024073B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 07/08/1999 | WO1999020739A3 Novel lactic acid bacteria species |
| 07/08/1999 | WO1999020639A3 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES |
| 07/08/1999 | WO1999020259A3 Compositions containing thiamphenicol and diclofenac |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999019304A9 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1999011606A3 Inhibitors of protein tyrosine phosphatase |
| 07/08/1999 | WO1999011604A9 Sterilized 5-aminolevulinic acid |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | WO1999009967B1 Cholesterol-lowering therapy |
| 07/08/1999 | DE19758059A1 Verwendung von Mannose zur Bekämpfung der Proteinverlust-Enteropathie Use of mannose to combat protein-losing enteropathy |
| 07/08/1999 | CA2317112A1 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities |
| 07/08/1999 | CA2317090A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system |
| 07/08/1999 | CA2316989A1 Hyperhydrated citicoline, process and use |
| 07/08/1999 | CA2316986A1 Aqueous liquid preparation |
| 07/08/1999 | CA2316444A1 11.beta.-halogen-7.alpha.-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11.beta.-halogen-7.alpha.-substituted estratrienesas well as their use for the production of pharmaceutical agents |
| 07/08/1999 | CA2316387A1 Sodium ion absorption inhibitors, sodium ion excretion accelerators, and agent for preventing and treating disease caused by excessive intake of common salt |
| 07/08/1999 | CA2316385A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | CA2316382A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them |
| 07/08/1999 | CA2316352A1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 07/08/1999 | CA2316341A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | CA2316320A1 Agent for suppressing bone-resorptive cytokine, containing dienogest as effective ingredient |
| 07/08/1999 | CA2316308A1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 07/08/1999 | CA2316303A1 Suppressing agent of angiogenesis, containing dienogest as effective ingredient |
| 07/08/1999 | CA2316275A1 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | CA2316235A1 Substituted .beta.-alanines |
| 07/08/1999 | CA2316221A1 Heterocyclic topoisomerase poisons |
| 07/08/1999 | CA2316218A1 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | CA2316041A1 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| 07/08/1999 | CA2315853A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof |
| 07/08/1999 | CA2315843A1 S-procyclidine for treating urinary incontinence |
| 07/08/1999 | CA2315840A1 R-procyclidine for treating urinary incontinence |
| 07/08/1999 | CA2315821A1 Acylphosphates and acylphosphonates as .beta.-lactamase and dd-peptidase inhibitors |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315297A1 Desaturase |
| 07/08/1999 | CA2315259A1 Pharmaceutical composition containing sibutramine and orlistat |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | CA2315055A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/08/1999 | CA2313487A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
| 07/08/1999 | CA2313230A1 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
| 07/08/1999 | CA2300479A1 Nitrogen-containing heterocyclic compounds, their production and use |
| 07/08/1999 | CA2282815A1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/08/1999 | CA2282458A1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/08/1999 | CA2281937A1 Drug for treating abnormalities in bone marrow |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927722A1 Beta, Beta-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A |
| 07/07/1999 | EP0927719A1 Triazole derivative or salt thereof, preparation process thereof as well as pharmaceutical containing said compound |